The availability and depiction of synthetic cathinones (bath salts) on the Internet: Do online suppliers employ features to maximize purchases?

International Journal of Drug Policy

Volumn 26, Issue 7, 2015, Pages 670-674

  Meyers, Kathleen ^a   Kaynak, Övgü ^a   Bresani, Elena ^a   Curtis, Brenda ^a,b   McNamara, Ashley ^a   Brownfield, Kristine ^a   Kirby, Kimberly C ^a,b  

^a TREATMENT RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bath salts; Designer drugs; Online designer drug suppliers

Indexed keywords

AMPHETAMINE DERIVATIVE; BATH SALT; CATHINONE; DESIGNER DRUG; UNCLASSIFIED DRUG; ALKALOID; STREET DRUG;

ACCESS TO INFORMATION; ADVERTIZING; ARTICLE; CATHA EDULIS; COMMERCIAL PHENOMENA; CONSUMER; DRUG INDUSTRY; GERMANY; HUMAN; INTERNET; LEGAL ASPECT; PRIORITY JOURNAL; PRODUCT SAFETY; PURCHASING; UNITED KINGDOM; UNITED STATES; WEB BROWSER; ECONOMICS; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; SUPPLY AND DISTRIBUTION;

ALKALOIDS; COMMERCE; DESIGNER DRUGS; HUMANS; INTERNET; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84930764891     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2015.01.012     Document Type: Article

References (42)

1. Adebamiro A., Perazella M.A. Recurrent acute kidney injury following bath salts intoxication. American Journal of Kidney Diseases 2012, 59(2):273-275. 10.1053/j.ajkd.2011.10.012.
2. Bruno R., Poesiat R., Matthews A.J. Monitoring the Internet for emerging psychoactive substances available to Australia. Drug and Alcohol Review 2013, 32(5):541-544.
3. CASA (National Center on Addiction and Substance Abuse) You've got drugs! Prescription drug pushers on the Internet 2006, CASA, New York, NY.
4. Corazza O., Assi S., Simonato P., Corkery J., Bersani F.S., Demetrovics Z., et al. Promoting innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances in the EU: The outcomes of the ReDNet project. Human Psychopharmacology: Clinical and Experimental 2013, 28(4):317-323.
5. Corazza O., Schifano F., Farre M., Deluca P., Davey Z., Drummond C., et al. Designer drugs on the Internet: A phenomenon out-of-control? The emergence of hallucinogenic drug Bromo-Dragonfly. Current Clinical Pharmacology 2011, 6(2):125-129.
6. Corazza O., Schifano F., Simonato P., Fergus S., Assi S., Stair J., et al. Phenomenon of new drugs on the Internet: The Case of ketamine derivative methoxetamine. Human Psychopharmacology: Clinical and Experimental 2012, 27(2):145-149.
7. Corazza O., Valeriani G., Bersani F.S., Corkery J., Martinotti G., Bersani G., et al. "Spice", "kryptonite", "black mamba": An overview of brand names and marketing strategies of novel psychoactive substances on the web. Journal of Psychoactive Drugs 2014, 46(4):287-294.
8. Curtis B., Alanis-Hirsch K., Kaynak Ö., Cacciola J., Meyers K., McLellan A.T. Using web searches to track interest in synthetic cannabinoids (aka herbal incense). Alcohol and Drug Review 2014, 10.1111/dar.12189.
9. Davies S., Wood D.M., Smith G., Button J., Ramsey J., Archer R., et al. Purchasing 'legal highs' on the Internet-Is there consistency in what you get?. Quarterly Journal of Medicine 2010, 103(7):489-493.
10. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) The State of the Drugs Problem in Europe 2012, Available from. http://www.emcdda.europa.eu/publications/annual-report/2012.
11. Forman R.F. Availability of opioids on the Internet. Journal of the American Medical Association 2003, 290(7):889.
12. Fox S. The Web at 25: Pew Internet Research Project 2014.
13. Haste H. Joined-up texting: Mobile phones and young people. Young Consumers: Insight and Ideas for Responsible Marketers 2005, 6(3):56-67.
14. INCB. (2013). Report of the International Narcotics Control Board for 2012. October 24, 2014, from http://incb.org/documents/Publications/AnnualReports/AR2012/AR_2012_E.pdf.
15. Jansen B.J., Spink A., Pedersen J. A temporal comparison of AltaVista web searching. Journal of the American Society for Information Science and Technology 2005, 56(6):559-570.
16. Jansen B.J., Spink A., Saracevic T. Real life, real users, and real needs: A study and analysis of user queries on the web. Information Processing & Management 2000, 36(2):207-227.
17. Jansen J. 65% of Internet users have paid for online content 2010, Pew Research Center's Internet & American Life Project, Washington, DC.
18. Karila L., Reynaud M. GHB and synthetic cathinones: Clinical effects and potential consequences. Drug Testing and Analysis 2011, 3(9):552-559. 10.1002/dta.210.
19. Kasick D.P., McKnight C.A., Klisovic E. Bath salt ingestion leading to severe intoxication delirium: Two cases and a brief review of the emergence of mephedrone use. American Journal of Drug and Alcohol Abuse 2012, 38(2):176-180. 10.3109/00952990.2011.643999.
20. Keen P., Ballance G., Chan S., Schrump S. Electronic commerce relationships: Trust by design 1999, Prentice Hall PTR.
21. McClean J.M., Anspikian A., Tsuang J.W. Bath salt use: A case report and review of the literature. Journal of Dual Diagnosis 2012, 8(3):250-256. 10.1080/15504263.2012.697447.
22. Murray B.L., Murphy C.M., Beuhler M.C. Death following recreational use of designer drug bath salts containing 3,4-methylenedioxypyrovalerone (MDPV). Journal of Medical Toxicology 2012, 8(1):69-75. 10.1007/s13181-011-0196-9.
23. National Conference of State Legislatures Synthetic Drug Threats 2012, Available from. http://www.ncsl.org/research/civil-and-criminal-justice/synthetic-drug-threats.aspx.
24. Olives T.D., Orozco B.S., Stellpflug S.J. Bath salts: The ivory wave of trouble. Western Journal of Emergency Medicine 2012, 13(1):58-62. 10.5811/westjem.2011.6.6782.
25. Orizio G., Merla A., Schulz P.J., Gelatti U. Quality of online pharmacies and websites selling prescription drugs: A systematic review. Journal of Medical Internet Research 2011, 13(3):e74. 10.2196/jmir.1795.
26. Parliamentary Counsel Office New Zealand Psychoactive Substances Act 2013 2013, Stat. Public Act 2013 No 53. July 17, 2013.
27. PayPal Acceptable Use Policy 2011, Available from. https://www.paypal.com/webapps/mpp/ua/acceptableuse-full.
28. Perrone D., Helgesen R.D., Fischer R.G. United States probation and legal highs: How drug testing may lead cannabis users to spice. Drugs: Education, Prevention and Policy 2013, 20(3):216-224.
29. Prosser J.M., Nelson L.S. The toxicology of bath salts: A review of synthetic cathinones. Journal of Medical Toxicology 2012, 8(1):33-42.
30. Purcell K., Brenner J., Rainie L. Search engine use 2012 2012, The Pew Research Center's Internet & American Life Project, Washington, DC.
31. Rosenbaum C.D., Carreiro S.P., Babu K.M. Here today, gone tomorrow and back again? A review of herbal marijuana alternatives (K2, spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. Journal of Medical Toxicology 2012, 8(1):15-32. 10.1007/s13181-011-0202-2.
32. Slomski A. A trip on bath salts is cheaper than meth or cocaine but much more dangerous. Journal of the American Medical Association 2012, 308(23):2445-2447. 10.1001/jama.2012.34423.
33. Stoica M.V., Felthous A.R. Acute psychosis induced by bath salts: A case report with clinical and forensic implications. Journal of Forensic Sciences 2013, 10.1111/1556-4029.12038.
34. Tan Y.-H., Thoen W. Toward a generic model of trust for electronic commerce. International Journal of Electronic Commerce 2001, 5:61-74.
35. Tan Y.-H., Thoen W. Formal aspects of a generic model of trust for electronic commerce. Decision Support Systems 2002, 33(3):233-246.
36. U.S.Department of Justice National Drug Intelligence Center Situation Report Product Number 2011-S0787-004, Synthetic Cathinones (bath salts): An emerging domestic threat July 2011, Available from. http://www.justice.gov/archive/ndic/pubs44/44571/44571p.pdf.
37. United Nations Office on Drugs and Crime (UNODC) World Drug Report 2012 2013, UNODC, Vienna.
38. Van der Heijden H., Verhagen T., Creemers M. Understanding online purchase intentions: Contributions from technology and trust perspectives. European Journal of Information Systems 2003, 12(1):41-48.
39. Venkatesh V., Davis F.D. A theoretical extension of the technology acceptance model: Four longitudinal field studies. Management Science 2000, 46(2):186-204.
40. Wilkins C. The interim regulated legal market for NPS ('legal high') products in New Zealand: The impact of new retail restrictions and product licensing. Drug Testing and Analysis 2014, 6:868-875.
41. Wilkins C. Letter to the Editor: Recent developments with the establishment of a regulated legal market for new psychoactive substances ('legal highs') in New Zealand. Drug and Alcohol Review 2014, 33:678-680.
42. Wood D.M., Dargan P.I. Mephedrone (4-methylmethcathinone): What is new in our understanding of its use and toxicity. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012, 39(2):227-233. 10.1016/j.pnpbp.2012.04.020.